<?xml version="1.0" encoding="UTF-8"?>
<svg height="712.2860000000001" width="532.5390677475" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 23 of 27</text>
  <text svg_rhmargin="169.849" x="76.186,83.162,88.64,91.626,97.105,102.09,105.578,109.837,116.311,121.296,126.774,129.76,133.248,136.234,141.712,147.191,150.177,153.163,158.148,163.626,167.607,169.849" y="55.95799999999997" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Author Contributions: </text>
  <text x="176.654,183.138,188.132,193.455,197.515,201.896,207.393,210.374,215.889,220.462,223.123,225.785,230.358,234.931,237.912,240.573,245.567,250.89,253.177,257.932,266.255,268.541,271.587,277.175,279.461,284.564,286.851,291.113,295.686,301.008,306.596,310.849,316.949,319.236,322.281,328.766,331.052,338.661,340.948,343.23499999999996,348.502,357.154,361.535,364.516,369.839,374.833,380.421,385.414,388.076,393.069,398.154,402.243,404.53,409.285,417.607,419.894,422.939,428.527,430.814,435.917,438.204,440.491,445.758,450.559,455.553,458.599,461.58,469.208,473.78,477.228,481.609,483.89599999999996,488.661,496.974,499.26,502.306,507.894,510.18,515.293,517.579" y="55.95799999999997" svg_rhmargin="519.865" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Conceptualization, W.-L.Y. and Z.-C.H.; Methodology, W.-L.Y.; Software, W.-L.Y.;</text>
  <text x="76.213,81.731,86.125,88.682,91.239,96.608,101.001,103.866,106.423,111.221,116.335,118.532,120.579,128.54,130.737,133.663,139.032,141.229,146.097,148.294,150.297,154.69,159.804,165.173,167.168,173.029,175.226,178.152,184.382,186.579,193.889,196.086,198.28300000000002,200.366,205.251,210.049,213.52,221.279,225.672,228.22899999999998,230.233,234.626,239.74,244.134,246.691,251.577,255.302,257.859,261.585,263.782,265.829,273.79,275.987,278.913,284.282,286.479,291.347,293.544,295.741,297.814,300.775,305.89,310.854,315.063,318.789,321.654,324.211,329.096,333.49,336.354,338.911,343.709,348.823,351.02,353.067,361.037,363.234,366.16,371.52,373.717,378.585,380.782,382.979,385.061,391.862,396.256,399.12,403.514,405.517,409.419,414.717,418.188,422.582,425.446,428.004,432.801,437.915,440.112,442.159,450.121,452.317,455.243,460.612,462.809,467.677,469.874,471.869,476.262,481.376,486.745,488.749,494.609,496.806,499.732,505.962,508.159,515.47,517.667" y="66.09000000000003" svg_rhmargin="519.864" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Validation, W.-L.Y. and Z.-C.H.; Formal analysis, W.-L.Y.; Investigation, W.-L.Y.; Data curation, W.-L.Y. and Z.-C.H.;</text>
  <text x="76.087,84.565,88.178,90.839,93.821,96.482,101.805,106.89,116.036,121.029,124.642,127.303,132.388,135.05,140.372,144.945,147.606,150.085,155.673,159.286,163.859,166.904,169.886,172.364,177.861,181.309,185.689,191.186,195.759,199.371,203.944,206.926,209.587,214.581,219.904,222.191,224.723,233.046,235.332,238.378,243.966,246.252,251.356,253.642,255.929,258.526,267.004,270.617,273.278,276.26,278.921,284.244,289.329,298.475,301.922,306.303,311.471,314.132,318.513,326.14099999999996,328.619,333.192,338.514,344.10200000000003,346.581,350.962,356.55,359.211,362.193,364.854,370.177,375.262,377.549,380.082,388.404,390.691,393.736,399.324,401.611,406.714,409.001,411.47,416.043,421.366,426.954,429.432,435.532,437.819,440.864,447.349,449.635,457.244,459.531,461.818,464.415,470.524,473.185,477.063,482.578,487.151,489.812,492.474,497.047,501.619,504.601,507.262,512.256,517.579" y="76.22199999999998" svg_rhmargin="519.865" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Writing—original draft preparation, W.-L.Y.; Writing—review and editing, W.-L.Y. and Z.-C.H.; Visualization,</text>
  <text x="76.087,84.228,86.47,89.456,94.934,97.176,102.161,104.403,106.64500000000001,108.886,113.871,119.278,124.497,129.975,132.584,137.803,142.788,145.03,149.513,153.494,158.515,163.922,166.531,170.333,172.942,175.865,178.474,183.37,188.588,190.82999999999998,193.072,199.052,201.294,204.28,210.637,212.878,220.339" y="86.35500000000002" svg_rhmargin="222.581" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">W.-L.Y.; Funding acquisition, Z.-C.H.</text>
  <text svg_rhmargin="113.647" x="76.535,81.52,86.999,92.477,97.956,100.942,106.42,111.405,113.647" y="102.46400000000006" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Funding: </text>
  <text x="116.447,121.866,127.012,129.585,133.334,135.587,139.336,142.218,147.549,152.951,157.867,160.112,167.485,171.906,175.655,177.909,181.657,186.988,192.302,197.615,202.442,205.934,208.816,213.051,218.45299999999997,220.707,223.28,228.425,230.68,235.993,240.414,243.906,246.788,249.034,253.923,258.839,261.093,266.008,269.5,273.921,279.066,281.948,285.697,287.951,290.895,294.219,299.046,306.853,309.107,311.989,317.135,321.37,323.624,330.971,335.391,338.273,340.846,345.673,350.819,355.239,357.81199999999995,360.057,366.476,370.71,375.626,377.88,383.786,390.664,397.507,399.762,405.667,409.902,413.651,417.885,422.306,425.639,429.564,434.709,436.955,442.295,445.628,450.455,455.371,458.863,463.283,471.09000000000003,473.344,478.233,483.149,485.394,493.758,496.33,501.476,504.049,507.797,510.679,514.171" y="102.46400000000006" svg_rhmargin="519.087" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">This study was supported in part by grants from the National Key R&amp;D Research Program by Ministry</text>
  <text x="76.535,81.529,84.575,87.912,92.714,96.774,99.436,103.817,109.14,113.2,117.581,120.919,125.492,130.815,136.403,139.741,144.524,148.905,152.966,158.289,163.611,168.605,171.266,176.26,181.345,186.43,189.768,192.814,200.414,205.407,207.69400000000002,213.767,218.34,222.912,227.485,232.058,238.158,242.576,249.691,254.264,258.837,263.41,267.983,272.555,277.128,281.701,284.747,287.034,290.646,295.219,300.541,306.129,309.468,312.449,317.772,322.153,325.491,331.975,337.298,339.959,345.282,349.663,353.541,357.922,361.26,368.86,373.433,376.414,379.076,384.069,389.392,393.965,396.626,399.965,407.565,412.138,415.119,420.634,424.246,428.819,431.48,434.819,439.62,443.681,446.343,450.723,456.046,460.107,464.488,468.366,471.704,476.789,481.782,487.297,492.62,498.208,502.781,505.762,508.424,513.417" y="112.596" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">of Science and Technology (No. 2017YFA0506002), and the Chinese National Natural Sciences Foundation</text>
  <text x="76.239,79.285,86.885,91.878,95.756,98.043,101.39,105.963,110.535,115.108,119.681,124.254,128.827,133.4,137.973,140.26000000000002,143.881,148.454,153.027,157.599,162.172,166.745,171.318,175.891,180.464,182.751,186.381,190.954,195.527,200.1,204.672,209.245,213.818,218.391,222.964,225.251,228.872,233.445,238.018,242.591,247.163,251.736,256.309,260.882,265.455,267.74199999999996,271.363,275.936,280.509,285.082,289.655,294.227,298.8,303.373,307.946,310.992,313.279,316.909,319.954,322.616,327.189,332.512,337.597,341.474,346.989,350.337,355.861,359.309,364.302,369.469,372.131,377.454,381.514,385.895,389.242,392.288,399.888,404.882,408.759,411.046,417.146,422.734,428.834,433.407,437.98,442.553,447.126,451.699,456.272,460.844,463.131,466.753,472.341,478.45,485.565,490.138,494.711,499.284,503.857,508.43,513.003,517.575" y="122.72799999999995" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">(Nos. 81630092, 31801084, 81773099, 81570790, 81573338), Jiangsu Province (Nos. BZ2017018, BRA2017347,</text>
  <text x="76.535,82.123,88.763,93.336,97.909,102.481,107.054,111.627,116.2,120.773,125.346,128.392,131.986,136.558,141.881,147.469,151.064,155.865,161.188,165.569,170.891,175.464,180.787,185.168,190.491,194.094,198.896,202.956,205.618,209.999,215.321,219.382,223.763,227.357,231.93,237.253,242.84099999999998,246.435,251.218,255.599,259.66,264.983,270.306,275.299,277.96,282.954,288.039,293.12399999999997,296.718,299.8,305.123,310.446,315.44,320.607,325.18,328.161,330.823,335.816,341.13899999999995,344.733,351.218,356.211,364.287,372.363,375.024,378.006,380.987,385.368,389.749,393.343,396.388,403.989,408.982,411.269,418.119,421.164,427.649,433.749,436.794,441.367,445.94,450.513,455.086,459.659,464.232,468.804,473.377,477.95,482.523,487.096,491.669,496.242,500.815,505.387,509.96,514.533,517.579" y="132.86" svg_rhmargin="519.865" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">BK20171202) and Shenzhen Science and Technology Innovation Committee (No. JCYJ20160331152141936),</text>
  <text x="76.535,81.242,86.461,90.756,95.974,100.457,105.676,109.971,115.18900000000001,117.431,122.846,127.141,131.625,135.606,140.501,144.482,149.467,151.709,157.125,159.734,164.217,169.435,171.677,174.663,182.114,187.01,189.25199999999998,192.031,198.541,205.588,211.085,218.025,222.508,226.991,231.474,235.958,240.441,244.924,249.407,253.89,258.374,262.857,267.34,271.823,276.306,280.79,285.273,289.756,294.239,297.225" y="142.99199999999996" svg_rhmargin="299.467" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Shenzhen Peacock Plan (No. KQTD20140630165057031).</text>
  <text svg_rhmargin="160.622" x="76.535,83.009,87.994,93.473,98.951,101.937,105.918,108.904,112.88499999999999,115.709,120.695,124.18299999999999,127.016,130.504,135.982,138.968,143.451,146.939,151.422,155.394,158.38,160.62199999999999" y="159.10199999999998" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Conﬂicts of Interest: </text>
  <text x="164.576,170.182,175.505,179.886,182.712,187.285,192.8,195.781,201.104,206.098,209.71,213.58800000000002,216.414,222.002,226.383,230.444,233.105,237.678,241.126,245.507,248.342,253.665,258.659,261.484,265.545,270.538,278.614,284.111,288.491,291.473,294.134,299.457,304.542,307.368,310.03,315.352,318.334,322.715,326.163,330.543,334.421,337.403,341.281,343.568,348.103,353.71,359.032,363.413,366.239,369.285,374.278,379.793,385.116,390.704,393.365,398.688,403.77299999999997,406.599,410.477,415.974,420.967,426.29,430.168,435.161,438.774,442.652,445.478,450.801,455.373,460.961,463.787,469.11,474.10400000000004,476.93,480.378,485.371,488.033,492.414,495.249,497.91,503.233,506.059,509.04,514.363" y="159.10199999999998" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The authors declare no competing interests. The founding sponsors had no role in the</text>
  <text x="76.535,82.019,86.318,90.124,92.736,97.726,102.949,105.193,110.094,113.083,115.336,118.261,123.485,127.784,130.028,133.834,136.76,142.172,147.656,152.646,154.89,157.143,159.755,164.978,167.231,170.157,175.381,179.68,181.924,185.909,190.809,193.421,196.033,200.332,204.317,207.243,209.855,214.756,219.979,222.223,224.476,228.964,234.187,238.675,241.287,246.277,250.083,254.382,258.187,260.43100000000004,262.675,267.576,271.12100000000004,273.374,275.986,281.209,284.135,288.434,291.98,297.374,300.758,305.057,307.983,312.47,315.396,318.008,322.909,328.132,330.376,335.277,338.26599999999996,340.518,346.002,350.49,353.416,357.904,360.148,362.4,365.012,370.235,372.48,375.405,380.629,384.928,387.172,394.658,398.203,400.815,403.741,406.352,411.576,416.56600000000003,418.819,423.72,426.709,428.952,431.878,437.102,441.40099999999995,443.654,451.579,456.067,461.291,466.703,470.508,474.493,478.039,480.651,486.045,488.971,491.21500000000003,493.458,497.946,503.17,508.654,510.906,513.518" y="169.23400000000004" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in</text>
  <text x="76.535,79.458,84.676,88.971,91.213,96.691,100.986,104.967,107.577,111.378,113.988,118.883,124.101,126.343,129.266,134.161,136.404,141.792,147.199,152.158,154.767,157.376,161.178,166.396,168.638,171.561,176.779,181.07399999999998,183.316,186.696,190.991,194.793,200.2,202.809,205.732,209.534" y="179.36599999999999" svg_rhmargin="211.776" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the decision to publish the results.</text>
  <text x="76.535,83.728,88.709,92.585,97.566,101.441,106.423,112.51,116.933,121.915" y="205.66700000000003" svg_rhmargin="126.338" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:9.96px;font-style:NORMAL;font-weight:BOLD;">References</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="224.55700000000002" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">1. </text>
  <text x="98.05,106.702,111.275,116.79,120.667,122.95400000000001,125.213,133.865,136.151,141.593,143.879,146.166,148.434,155.412,158.951,164.466,169.963,175.459,177.746,180.005,184.806,187.093,194.208,196.495,198.782,201.049,206.573,211.567,215.179,218.161,222.542,225.487,227.774,230.032,237.111,239.397,244.985,247.272,249.559,251.826,254.872,260.387,265.7,270.081,272.368,274.627,281.111,283.397,291.007,293.294,295.552,302.667,307.99,310.972,313.633,318.691,323.684,329.272,334.357,337.403,345.479,350.472,356.06,358.722,364.255,368.636,374.22400000000005,376.483,382.089,384.348,388.409,392.789,395.451,398.112,401.99,404.277,407.084,413.569,420.684,426.793,430.671,432.93,435.912,440.484,445.569,449.95000000000005,452.2,455.182,460.504,464.885,467.144,470.19,473.647,478.64,483.963,486.94500000000005,489.195,493.072,497.453,502.026,505.00800000000004,507.267,510.312,515.306" y="224.55700000000002" svg_rhmargin="518.919" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Maus, M.V.; Grupp, S.A.; Porter, D.L.; June, C.H. Antibody-modiﬁed T cells: CARs take the front seat for</text>
  <text svg_rhmargin="203.558" x="98.05,103.268,107.563,115.481,119.964,122.887,127.783,130.392,135.287,140.273,142.882,146.863,149.105,157.022,161.505,164.114,166.724,171.709,176.927,181.411,186.629,190.61,193.219,197.514,201.316,203.558" y="237.46799999999996" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">hematologic malignancies. </text>
  <text svg_rhmargin="226.752" x="206.336,211.814,214.307,218.288,222.269,226.752" y="237.46799999999996" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Blood </text>
  <text x="228.994,233.477,237.96,242.444" y="237.46799999999996" svg_rhmargin="246.927" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2014</text>
  <text svg_rhmargin="249.169" x="246.927,249.16899999999998" y="237.46799999999996" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="251.41,255.893,260.376" y="237.46799999999996" svg_rhmargin="264.859" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">123</text>
  <text x="264.859,267.101,269.342,273.825,278.309,282.792,287.275,291.758,296.242,300.725,305.208,309.691,311.933,314.712,317.698,324.055,327.436,332.331,336.133,339.935,345.924,350.219,353.205,356.191,358.432,361.418,366.834,372.241,377.199,385.681,389.976,395.455" y="237.46799999999996" svg_rhmargin="398.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 2625–2635. [CrossRef] [PubMed]</text>
  <text x="76.535,81.018,83.26,98.054,104.035,109.253,113.737,118.955,123.94,126.182,128.415,133.247,135.489,137.731,139.963,146.32,150.804,155.699,157.941,160.183,165.661,167.903,170.14499999999998,172.377,178.357,180.967,185.262,187.504,189.736,192.722,194.963,197.20499999999998,199.446,204.154,209.372,211.981,214.22299999999998,216.456,223.907,226.148,228.39,230.632,236.612,241.831,246.314,251.532,256.518,258.76,260.992,266.972,269.214,271.456,273.688,279.167,284.574,289.469,291.711,293.952,299.933,302.175,304.41700000000003,306.649,311.822,317.229,321.524,323.766,325.998,332.938,335.18,337.422,339.663,345.644,350.862,355.345,360.564,365.549,367.791,370.023,376.004,378.246,380.488,382.729,390.87,395.354,400.572,405.557,407.79900000000004,410.032,415.51,417.752,419.994,422.226,429.686,434.169,439.388,441.63,443.871,452.012,454.254,456.49600000000004,458.728,463.023,465.946,468.179,472.662,475.271,477.51300000000003,480.292,485.771,488.595,494.02,498.001,500.61,504.905,510.123,514.105" y="250.38" svg_rhmargin="519.09" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">2. Zhang, T.; Cao, L.; Xie, J.; Shi, N.; Zhang, Z.; Luo, Z.; Yue, D.; Zhang, Z.; Wang, L.; Han, W.; et al. Efﬁciency</text>
  <text x="98.05,103.014,106.042,108.288,114.734,121.771,126.317,130.863,133.108,137.145,142.437,145.083,153.111,157.466,161.057,163.703,167.74,169.985,174.531,179.823,182.787,185.433,190.488,194.843,200.135,202.38,205.817,210.172,214.209,218.564,224.028,226.992,231.956,235.384,238.411,246.439,251.404,256.959,259.605,265.105,269.46,275.015,277.261,282.834,285.08,289.117,293.472,296.118,298.763,302.618,304.864,307.892,312.856,316.447,318.693,321.657,325.085,329.44,333.986,336.95,344.978,349.333,354.624,357.588,359.834,364.798,367.826,370.071,375.62600000000003,377.881,381.909,386.264,388.91,391.55600000000004,393.81,401.839,406.385,409.03,411.676,416.731,422.023,426.569,431.86,435.897,438.534,442.889,446.744,448.998,451.644,456.936,459.181,464.646,469.937,474.483,478.338,482.69300000000004,484.939,488.00300000000004,490.249,494.285,496.931,499.577,504.868,507.514,511.551,516.097" y="263.29100000000005" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">of CD19 chimeric antigen receptor-modiﬁed T cells for treatment of B cell malignancies in phase I clinical</text>
  <text svg_rhmargin="189.095" x="98.05,100.973,104.515,107.124,111.607,114.216,118.018,120.26,123.039,130.01500000000001,132.257,140.174,144.469,147.392,151.875,154.861,159.344,164.563,169.046,171.655,176.64,180.442,183.051,186.853,189.095" y="276.203" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">trials: A meta-analysis. </text>
  <text svg_rhmargin="232.716" x="191.874,198.85,203.835,207.484,211.466,214.451,218.432,221.759,226.242,229.73,232.71599999999998" y="276.203" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Oncotarget </text>
  <text x="234.956,239.439,243.922,248.406" y="276.203" svg_rhmargin="252.889" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2015</text>
  <text svg_rhmargin="255.131" x="252.889,255.131" y="276.203" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="257.372" y="276.203" svg_rhmargin="261.855" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">6</text>
  <text x="261.856,264.098,266.339,270.822,275.306,279.789,284.272,288.755,293.238,297.722,302.205,306.688,311.171,315.655,317.897,320.676,323.662,330.019,333.399,338.295,342.096,345.898,351.888,356.183,359.168,362.154,364.396,367.382,372.797,378.204,383.163,391.645,395.94,401.418" y="276.203" svg_rhmargin="404.404" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 33961–33971. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="289.115" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">3. </text>
  <text x="98.05,102.833,107.827,113.323,117.896,120.558,123.219,127.792,133.115,135.40200000000002,137.825,142.626,144.913,150.501,152.787,155.074,157.589,165.911,170.905,173.566,177.627,182.95,187.943,193.028,195.315,197.738,200.784,203.07,210.149,212.436,214.723,217.237,223.721,229.044,233.617,238.94,241.227,243.65,248.589,250.875,257.991,260.277,262.56399999999996,265.078,273.73,278.111,280.773,283.434,291.51,296.083,301.405,303.69199999999995,306.115,309.198,311.484,313.77099999999996,316.285,321.809,326.382,329.044,334.559,338.619,343.704,348.277,350.56399999999996,352.987,359.627,361.914,364.20099999999996,366.715,372.303,376.876,382.199,386.259,391.582,395.963,399.411,403.792,408.365,413.88,416.167,418.59,421.635,423.922,426.209,428.723,434.832,439.826,443.704,448.085,453.407,458.465,462.846,466.303,471.388,473.67499999999995,476.098,480.899,483.186,490.301,492.588,494.875,497.389,504.468,509.041,514.364" y="289.115" svg_rhmargin="518.745" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Topalian, S.L.; Wolchok, J.D.; Chan, T.A.; Mellman, I.; Palucka, K.; Banchereau, J.; Rosenberg, S.A.; Dane</text>
  <text svg_rhmargin="369.459" x="97.602,106.254,108.915,111.897,114.878,118.418,123.933,129.429,131.716,134.953,141.593,143.88,147.108,150.19,158.266,166.341,171.856,177.179,182.173,185.154,190.477,194.858,198.47,203.043,208.54,213.625,215.912,220.676,226.282,231.605,235.986,239.214,244.711,249.284,252.265,257.58799999999997,260.826,263.807,268.80100000000004,272.029,279.657,282.318,287.64099999999996,290.879,293.86,299.183,303.56399999999996,306.792,314.42,318.993,322.606,325.843,330.836,336.159,339.388,343.448,348.021,353.344,357.405,361.785,365.398,369.459" y="302.026" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Wittrup, K. Immunotherapy: The path to win the war on cancer? </text>
  <text svg_rhmargin="389.959" x="375.216,381.316,384.874,387.416,389.959" y="302.026" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Cell </text>
  <text x="393.192,397.675,402.158,406.642" y="302.026" svg_rhmargin="411.125" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2015</text>
  <text svg_rhmargin="413.411" x="411.125,413.412" y="302.026" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="416.892,421.465,426.038" y="302.026" svg_rhmargin="430.611" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">161</text>
  <text x="430.611,432.89799999999997,436.382,440.955,445.528,450.101,454.673,459.246,463.819,468.392,470.679,476.431,479.477,485.961,489.409,494.403,498.28,502.158,508.267,512.648,515.694" y="302.026" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 185–186. [CrossRef]</text>
  <text x="98.05,101.036,106.452,111.858,116.817,125.299,129.594,135.072" y="314.938" svg_rhmargin="138.058" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">[PubMed]</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="327.849" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">4. </text>
  <text x="98.05,102.615,107.013,112.132,117.023,119.222,121.465,127.332,129.531,132.46,134.659,136.858,139.101,143.719,149.023,154.142,156.341,158.593,164.46,166.659,171.523,173.722,175.92100000000002,178.173,185.491,190.795,195.193,200.313,205.203,207.40200000000002,209.645,216.031,218.23,226.551,228.75,230.949,233.192,239.059,244.179,248.577,253.696,258.586,260.785,263.028,268.403,270.602,272.801,275.044,280.084,284.482,289.601,294.492,296.69100000000003,298.934,304.801,307.0,311.618,313.817,316.016,318.259,324.126,328.928,334.232,336.43100000000004,338.674,345.482,347.681,354.49,356.689,358.88800000000003,361.139,369.109,373.507,378.626,383.517,385.716,387.959,393.333,395.532,397.731,399.974,407.943,412.341,415.816,420.935,425.738,429.643,434.534,436.733,438.976,445.687,447.886,453.26,455.459,457.658,459.901,466.709,471.107,473.667,475.866,478.118,483.492,485.691,488.62,490.819,493.01800000000003,495.261,500.636,505.94,510.742,512.941,515.184,518.113" y="327.849" svg_rhmargin="520.312" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Tang, X.J.; Sun, X.Y.; Huang, K.M.; Zhang, L.; Yang, Z.S.; Zou, D.D.; Wang, B.; Warnock, G.L.; Dai, L.J.; Luo, J.</text>
  <text x="97.773,103.379,108.702,113.083,116.696,121.268,126.765,131.146,136.661,139.642,142.304,146.365,148.962,154.458,159.452,162.433,166.814,172.137,175.118,177.78,182.353,185.014,187.611,192.605,195.65099999999998,198.257,204.741,211.857,217.966,221.012,226.618,229.215,233.276,237.657,240.318,242.98,246.025,251.613,255.994,259.607,262.268,267.435,271.816,277.404,280.002,284.382,289.102,294.095,297.973,302.966,311.042,315.423,319.301,321.58799999999997,325.081,332.197,334.794,338.854,343.235,345.897,348.558,351.603,354.649,358.106,362.487,366.86800000000005,369.465,377.541,382.534,388.122,392.695,395.357,398.018,401.0,406.085,408.682,411.727,416.721,420.334,422.931,425.912,430.485,433.942,439.027,443.408,446.39,450.771,456.35900000000004,458.956,463.017,467.59,472.912,476.973,481.354,484.967,487.564,490.545,495.868,500.249,503.861,508.434,513.931,518.019" y="340.761" svg_rhmargin="520.305" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Therapeutic potential of CAR-T cell-derived exosomes: A cell-free modality for targeted cancer therapy.</text>
  <text svg_rhmargin="138.543" x="97.701,104.677,109.662,113.312,117.293,120.278,124.259,127.586,132.069,135.557,138.54299999999998" y="353.673" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Oncotarget </text>
  <text x="140.784,145.267,149.75,154.234" y="353.673" svg_rhmargin="158.717" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2015</text>
  <text svg_rhmargin="160.958" x="158.716,160.958" y="353.673" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="163.2" y="353.673" svg_rhmargin="167.683" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">6</text>
  <text x="167.683,169.92499999999998,172.166,176.649,181.133,185.616,190.099,194.582,199.065,203.549,208.032,212.515,216.998,221.481,223.72299999999998,226.503,229.488,235.846,239.226,244.122,247.923,251.725,257.715,262.01,264.995,267.981,270.223,273.209,278.624,284.031,288.989,297.472,301.767,307.245" y="353.673" svg_rhmargin="310.231" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 44179–44190. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="366.584" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">5. </text>
  <text svg_rhmargin="470.956" x="98.05,106.363,110.756,115.642,119.851,124.06,126.257,127.979,136.291,138.488,143.101,145.298,147.495,149.393,154.006,159.12,163.918,168.716,173.601,175.798,177.529,184.365,186.562,191.931,194.12800000000001,195.85,202.08,207.194,211.588,214.145,216.702,220.911,226.025,230.911,235.12,238.846,240.576,243.441,248.239,249.961,253.862,258.976,261.533,269.292,273.501,276.972,279.529,283.43,285.153,289.547,294.661,297.525,300.082,304.968,309.177,314.291,316.022,319.326,323.535,327.436,331.646,336.927,339.791,344.589,348.06,349.791,352.717,358.947,365.783,371.653,374.579,377.505,382.891,384.614,388.515,392.724,395.281,397.838,399.561,402.425,407.539,411.748,415.219,419.613,424.894,429.78000000000003,431.511,434.437,439.234,442.705,444.427,448.329,452.722,457.837,461.738,465.947,468.759,470.956" y="366.584" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Magee, M.S.; Snook, A.E. Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer. </text>
  <text x="473.56,480.396,482.839,486.257,489.834,493.735,497.637,499.834,501.556,509.851,513.269,517.662" y="366.584" svg_rhmargin="519.859" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Discov. Med.</text>
  <text x="98.05,102.533,107.016,111.5" y="379.496" svg_rhmargin="115.983" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2014</text>
  <text svg_rhmargin="118.225" x="115.983,118.22500000000001" y="379.496" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="120.466,124.949" y="379.496" svg_rhmargin="129.432" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">18</text>
  <text x="129.433,131.67499999999998,133.916,138.399,142.883,147.366,151.849,156.332,160.815,165.299,167.541,170.32,173.306,178.721,184.128,189.086,197.569,201.864,207.342" y="379.496" svg_rhmargin="210.328" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 265–271. [PubMed]</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="392.407" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">6. </text>
  <text x="98.05,104.657,109.626,113.667,118.964,123.323,128.62,134.181,138.54,142.135,145.165,149.525,152.455,154.73000000000002,156.978,160.009,162.284,169.847,172.122,174.39700000000002,176.645,185.255,187.903,190.551,194.41,199.379,204.676,206.951,209.19,217.472,219.747,227.319,229.594,231.869,234.117,237.148,241.699,246.995,249.644,254.704,256.979,259.227,262.257,264.533,270.093,272.369,274.644,276.892,283.936,289.424,294.984,297.633,301.992,306.051,308.32599999999996,310.574,319.184,321.459,327.019,329.295,331.57,333.818,338.596,341.563,345.922,348.889,351.537,355.897,359.328,362.358,367.136,370.103,374.462,379.604,383.964,389.261,393.119,398.088,403.385,405.65999999999997,407.908,416.518,418.793,421.068,423.316,428.376,432.736,435.384,440.945,448.981,453.531,458.828,461.10299999999995,463.351,468.129,470.404,477.485,479.76,482.03499999999997,484.283,492.893,497.443,501.038,503.686,507.727,510.00199999999995,512.241,515.308,517.583" y="392.407" svg_rhmargin="519.858" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Kochenderfer, J.N.; Wilson, W.H.; Janik, J.E.; Dudley, M.E.; Stetler-Stevenson, M.; Feldman, S.A.; Maric, I.;</text>
  <text x="98.05,104.028,108.502,111.321,114.3,118.587,121.191,126.658,128.895,131.141,139.607,141.844,144.081,146.327,153.763,158.237,161.155,166.363,170.837,176.045,178.28199999999998,180.519,187.445,189.682,196.644,198.881,201.118,203.365,208.832,213.306,218.514,221.118,225.405,228.277,230.51399999999998,232.76,238.228,240.465,243.445,245.682,247.91899999999998,250.165,254.451,257.368,259.615,264.089,266.693,268.93,271.713,277.18,280.715,285.189,290.657,293.261,297.234,301.708,304.625,307.229,312.115,317.32300000000004,319.569,324.455,327.435,329.681,335.14,338.119,340.723,343.327,348.535,352.822,357.296,362.271,366.557,368.804,372.777,377.063,379.667,382.271,386.065,388.311,392.786,397.994,403.461,405.707,409.081,413.367,418.342,421.716,426.002,429.797,433.591,436.195,441.081,446.28900000000004,448.526,453.412,456.392,458.637,461.241,466.217,474.118,479.496,484.704,489.59,497.492,501.966,504.212,506.816,512.024,514.27" y="405.319" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Raffeld, M.; Nathan, D.A.; Lanier, B.J.; et al. Eradication of B-lineage cells and regression of lymphoma in a</text>
  <text svg_rhmargin="413.352" x="97.781,103.073,107.475,110.346,112.908,117.126,122.25,125.12,127.366,130.236,133.556,137.773,142.176,145.046,149.264,154.644,156.889,164.232,166.795,169.665,174.79,177.035,181.437,186.747,189.617,194.425,196.987,201.794,206.69,211.498,216.807,220.54,222.794,228.191,230.437,234.347,238.564,241.126,243.689,247.422,249.667,254.563,258.78,263.905,268.123,270.993,273.555,277.465,281.867,284.429,286.992,291.88800000000003,294.141,298.35,303.475,308.37,310.932,316.057,320.275,324.492,327.812,332.029,337.409,339.654,342.525,347.33299999999997,349.586,352.897,357.115,361.024,365.832,370.727,375.852,378.414,382.816,387.034,389.288,395.531,402.346,406.748,411.151,413.35200000000003" y="418.231" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">patient treated with autologous T cells genetically engineered to recognize CD19. </text>
  <text svg_rhmargin="436.196" x="416.147,421.527,423.975,427.884,431.793,436.196" y="418.231" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Blood </text>
  <text x="438.444,442.927,447.41,451.894" y="418.231" svg_rhmargin="456.377" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2010</text>
  <text svg_rhmargin="458.578" x="456.377,458.57800000000003" y="418.231" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="460.827,465.229,469.632" y="418.231" svg_rhmargin="474.035" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">116</text>
  <text x="474.035,476.23600000000005,478.482,482.884,487.287,491.689,496.092,500.494,504.897,509.299,513.702,518.104" y="418.231" svg_rhmargin="520.305" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 4099–4102.</text>
  <text x="98.05,101.036,107.393,110.773,115.669,119.471,123.272,129.262,133.557,136.543,139.529,141.77,144.756,150.172,155.578,160.537,169.019,173.314,178.792" y="431.142" svg_rhmargin="181.778" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">[CrossRef] [PubMed]</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="444.054" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">7. </text>
  <text x="98.05,104.534,109.107,112.72,118.216,122.597,127.92,130.581,133.563,138.556,140.84300000000002,144.09,150.574,152.86,155.14700000000002,158.887,167.539,170.201,172.862,177.856,183.178,187.559,189.846,193.083,201.735,204.022,210.506,212.792,215.079,218.829,226.438,231.011,234.888,238.766,243.339,248.653,250.94,254.186,260.295,262.582,264.86899999999997,268.609,273.41,276.072,284.147,289.141,294.464,298.845,301.826,304.113,307.359,310.405,312.691,319.175,321.462,323.74899999999997,327.489,333.077,337.65,342.735,348.058,352.631,355.292,357.57899999999995,360.825,369.477,371.763,374.04999999999995,377.79,382.592,388.107,393.43,398.423,402.301,407.386,410.047,412.334,415.571,424.223,426.51,435.162,437.448,439.73499999999996,443.484,449.255,453.828,457.285,461.666,464.327,468.9,471.946,478.055,483.049,488.371,492.752,498.075,502.648,504.935,508.172,515.287,517.574" y="444.054" svg_rhmargin="519.86" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Carpenito, C.; Milone, M.C.; Hassan, R.; Simonet, J.C.; Lakhal, M.; Suhoski, M.M.; Varela-Rohena, A.;</text>
  <text x="98.05,105.659,110.232,112.894,118.216,122.597,126.475,128.762,132.191,138.831,141.117,149.769,152.056,154.34300000000002,158.375,165.984,170.365,173.027,176.008,178.148,182.721,188.044,190.33100000000002,193.76,200.839,203.125,207.387,209.674,211.961,215.993,223.1,225.761,230.819,235.199,237.861,243.449,248.022,250.309,253.747,258.548,260.835,269.487,271.773,274.06,278.084,282.465,285.447,288.885,293.458,296.119,298.406,304.753,311.237,316.231,321.553,324.535,327.992,332.985,335.646,339.077,344.07,347.116,350.545,353.207,357.78,361.237,366.322,370.702,372.989,376.72,381.101,384.979,387.96,392.533,397.591,400.252,402.914,406.791,412.114,416.495,422.083,425.513,428.494,434.009,442.085,447.078,450.691,454.121,458.84,463.221,468.543,473.537,478.622,482.235,486.807,489.853,492.834,496.712,500.151,507.779,510.44,513.422" y="456.966" svg_rhmargin="518.745" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Haines, K.M.; Heitjan, D.F.; Albelda, S.M.; et al. Control of large, established tumor xenografts with</text>
  <text svg_rhmargin="394.046" x="98.05,103.005,107.275,112.462,116.731,119.636,122.23,126.187,130.643,133.237,135.831,140.78699999999998,143.032,146.392,150.661,153.567,158.023,161.383,166.338,170.607,173.513,177.782,183.228,185.474,190.661,196.035,203.905,208.361,213.548,215.794,221.258,223.504,227.461,231.73,234.324,236.917,240.696,242.942,246.899,251.766,256.953,259.858,264.315,266.908,272.095,274.689,279.876,284.832,287.077,293.396,300.295,304.751,309.20799999999997,311.453,315.91,321.097,326.543,328.788,335.107,342.006,346.462,350.918,355.375,357.621,363.066,367.932,375.802,380.259,382.852,388.039,391.818,394.046" y="469.877" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">genetically retargeted human T cells containing CD28 and CD137 domains. </text>
  <text svg_rhmargin="497.45" x="396.836,402.282,405.588,409.545,413.173,415.401,418.191,425.125,429.082,432.05,434.527,436.755,439.554,445.989,449.616,453.574,458.03,460.258,463.048,468.003,471.631,474.108,476.336,479.126,486.06,491.015,497.45" y="469.877" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Proc. Natl. Acad. Sci. USA </text>
  <text x="499.7,504.183,508.666,513.15" y="469.877" svg_rhmargin="517.633" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2009</text>
  <text x="517.633" y="469.877" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="97.602,102.085,106.568" y="482.789" svg_rhmargin="111.051" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">106</text>
  <text x="111.052,113.29400000000001,115.535,120.018,124.502,128.985,133.468,137.951,142.434,146.918,151.401,155.884,158.12599999999998,160.905,163.891,170.248,173.629,178.524,182.326,186.128,192.117,196.412,199.398" y="482.789" svg_rhmargin="202.384" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 3360–3365. [CrossRef]</text>
  <text svg_rhmargin="83.26" x="76.535,81.018,83.26" y="495.7" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">8. </text>
  <text x="98.05,103.83,108.403,113.726,116.021,121.609,125.99,129.603,131.907,136.709,139.691,144.071,149.156,153.537,158.86,161.14700000000002,163.442,168.243,170.53,173.575,175.862,178.149,180.471,188.081,192.653,200.729,203.391,207.771,213.094,215.381,217.685,226.337,228.624,230.911,233.233,238.035,242.607,248.195,252.576,255.238,259.811,262.472,267.795,270.082,272.386,281.038,283.325,285.62,291.226,296.549,300.92999999999995,303.225,308.722,314.045,318.618,322.23,330.306,334.879,338.939,343.933,346.594,351.588,356.673,361.758,364.063,369.056,372.102,374.397,378.275,382.656,386.717,391.71,397.033,402.621,405.667,410.752,415.132,420.455,424.836,428.449,433.021,436.003,438.664,443.658,448.981,451.276,455.337,460.66,463.321,471.397,475.778,479.39,482.052,486.113,488.417,492.99,498.313,501.294,503.956,509.041,513.421" y="495.7" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Van der Stegen, S.J.; Hamieh, M.; Sadelain, M. The pharmacology of second-generation chimeric antigen</text>
  <text svg_rhmargin="136.794" x="98.05,101.43,105.725,109.706,114.001,119.39,122.313,127.209,130.75,134.552,136.79399999999998" y="508.612" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">receptors. </text>
  <text svg_rhmargin="226.01" x="139.573,146.549,150.53,153.516,155.75799999999998,158.537,164.518,168.005,171.996,174.238,177.017,183.993,187.48,192.466,196.949,199.191,206.166,208.659,212.147,215.796,219.777,223.768,226.01" y="508.612" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Nat. Rev. Drug Discov. </text>
  <text x="228.788,233.271,237.754,242.238" y="508.612" svg_rhmargin="246.721" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2015</text>
  <text svg_rhmargin="248.962" x="246.72,248.962" y="508.612" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="251.204,255.687" y="508.612" svg_rhmargin="260.17" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">14</text>
  <text x="260.17,262.41200000000003,264.653,269.136,273.62,278.103,282.586,287.069,291.552,296.036,298.278,301.057,304.043,310.4,313.78,318.676,322.478,326.279,332.269,336.564,339.55" y="508.612" svg_rhmargin="342.536" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 499–509. [CrossRef]</text>
  <text x="76.535,81.018,83.26,98.05,105.012,107.616,110.22,114.506,119.482,123.016,127.49,129.727,131.965,138.927,141.164,143.40099999999998,145.638,148.654,153.862,159.07,163.544,168.43,170.667,172.904,178.21,180.448,182.685,184.922,191.749,196.036,199.57,204.045,208.018,212.304,214.541,216.778,223.704,225.942,228.179,230.416,236.053,240.519,245.986,251.454,254.058,259.266,263.552,266.156,268.76,271.364,273.601,275.838,282.764,285.001,287.238,289.476,297.941,303.337,307.131,312.017,314.621,317.225,322.433,327.319,329.55600000000004,331.793,338.138,340.375,342.612,349.574,355.041,359.927,365.305,368.222,370.826,375.882,380.168,382.406,385.01,392.911,400.813,406.208,411.417,416.302,419.22,424.428,428.714,432.249,436.723,442.101,447.076,449.313,452.293,457.179,460.71299999999997,462.951,468.159,472.445,480.347,484.821,487.738,492.624,495.228,500.114,505.089,507.693,511.666,516.14" y="521.524" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">9. Allegra, A.; Innao, V.; Gerace, D.; Vaddinelli, D.; Musolino, C. Adoptive immunotherapy for hematological</text>
  <text svg_rhmargin="417.882" x="98.05,105.809,110.203,112.76,115.317,120.202,125.316,129.71,134.824,138.725,141.282,145.491,149.217,151.41400000000002,154.147,160.377,165.675,169.146,172.45,176.659,181.773,184.638,186.782,190.508,193.372,197.766,200.63,205.929,209.655,211.799,216.192,221.306,226.675,228.819,233.933,238.142,245.47,247.615,250.172,255.286,259.012,261.569,266.454,271.568,274.433,278.159,280.303,282.86,287.974,290.118,294.019,299.133,301.69,309.449,313.658,317.129,319.686,323.587,325.732,330.125,335.239,338.104,340.661,345.547,349.756,354.86999999999995,357.014,360.326,364.535,368.437,372.646,377.927,380.792,385.589,389.06,391.204,396.59000000000003,398.735,402.636,406.845,409.402,411.959,415.685,417.882" y="534.435" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">malignancies: Current status and new insights in chimeric antigen receptor T cells. </text>
  <text svg_rhmargin="496.989" x="420.629,425.998,428.441,432.342,436.244,440.63800000000003,442.781,448.642,452.06,454.503,456.946,460.36400000000003,462.508,470.803,474.705,477.147,479.344,482.095,488.931,491.374,494.792,496.989" y="534.435" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Blood Cells Mol. Dis. </text>
  <text x="499.732,504.215,508.698,513.182" y="534.435" svg_rhmargin="517.665" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text x="517.664" y="534.435" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="98.05,102.533" y="547.347" svg_rhmargin="107.016" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">62</text>
  <text x="107.017,109.259,111.5,115.983,120.467,124.95,129.433,133.916,136.158,138.937,141.923,148.28,151.661,156.556,160.358,164.16,170.149,174.444,177.43" y="547.347" svg_rhmargin="180.416" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 49–63. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="560.258" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">10. </text>
  <text x="98.05,103.327,107.708,112.793,118.308,120.59500000000001,123.658,130.847,133.133,140.322,142.608,144.895,148.37,153.958,157.406,161.787,167.109,170.091,172.231,176.612,181.935,185.812,188.09900000000002,191.163,197.272,199.558,202.604,204.89100000000002,207.954,215.07,218.682,226.758,231.751,235.209,239.589,245.177,248.241,254.725,261.841,267.951,271.014,276.126,279.172,283.233,287.613,290.275,292.936,296.814,299.101,303.518,310.633,313.615,316.276,318.938,321.599,326.172,328.833,334.156,339.241,342.305,346.366,351.451,354.432,359.426,364.511,367.172,372.495,376.876,380.75399999999996,383.817,388.39,393.713,399.30100000000004,402.365,407.862,411.319,416.312,419.358,422.019,427.342,432.902,437.475,445.551,453.627,458.2,461.181,466.175,469.787,474.87199999999996,477.936,480.597,483.259,488.344,492.917,498.24,503.828,507.70599999999996,510.769,513.751" y="560.258" svg_rhmargin="518.745" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Yeku, O.O.; Brentjens, R.J. Armored CAR T-cells: Utilizing cytokines and pro-inﬂammatory ligands to</text>
  <text svg_rhmargin="260.064" x="98.05,102.345,107.563,112.782,117.265,122.483,126.465,130.76,133.001,139.358,146.334,152.323,154.565,159.568,162.554,166.535,170.83,173.44,176.049,178.29,182.774,187.992,190.915,193.524,196.51,199.433,204.84,212.757,217.653,223.06,226.602,228.843,233.138,235.962,241.387,245.368,249.851,253.832,257.822,260.064" y="573.17" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">enhance CAR T-cell anti-tumour efﬁcacy. </text>
  <text svg_rhmargin="338.716" x="262.842,268.32,270.813,274.794,278.444,282.927,286.415,293.391,295.63300000000004,298.412,303.397,307.378,311.027,313.269,316.049,320.532,324.02,328.001,332.986,336.474,338.716" y="573.17" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Biochem. Soc. Trans. </text>
  <text x="341.494,345.977,350.46,354.944" y="573.17" svg_rhmargin="359.427" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text svg_rhmargin="361.668" x="359.426,361.668" y="573.17" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="363.91,368.393" y="573.17" svg_rhmargin="372.876" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">44</text>
  <text x="372.876,375.118,377.359,381.842,386.326,390.809,395.292,399.775,404.259,408.742,410.98400000000004,413.763,416.749,423.106,426.486,431.382,435.184,438.985,444.975,449.27,452.256" y="573.17" svg_rhmargin="455.242" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 412–418. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="586.082" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">11. </text>
  <text x="98.05,102.852,110.927,113.589,116.57,121.893,124.18,126.457,132.045,134.331,136.618,138.913,144.529,148.909,154.232,158.613,161.274,163.936,168.509,170.796,173.072,179.712,181.999,184.276,190.76,195.845,198.827,203.82,208.905,211.567,216.89,221.271,223.548,229.657,234.038,236.699,241.08,245.653,249.531,253.912,256.189,260.99,266.075,271.398,276.986,280.434,285.428,293.503,297.884,300.171,303.024,306.106,311.429,316.926,321.498,324.48,327.141,331.522,336.845,339.82700000000006,342.113,348.597,353.17,356.618,360.999,363.276,366.322,371.315,374.928,377.205,382.007,384.668,390.256,394.63699999999994,396.914,402.502,405.392,408.429,412.809,416.87,419.852,423.72999999999996,426.016,431.009,434.055,436.332,442.816,449.932,456.04200000000003,458.318,463.431,466.476,472.961,477.342,480.003,482.664,484.942,490.548,495.871,500.252,503.864,508.437,513.934,518.022" y="586.082" svg_rhmargin="520.308" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Smith, L.; Venella, K. Cytokine Release Syndrome: Inpatient Care for Side Effects of CAR T-Cell Therapy.</text>
  <text svg_rhmargin="174.481" x="97.755,103.736,106.228,108.721,113.706,115.94800000000001,118.727,121.713,123.955,126.196,133.172,138.158,141.807,145.788,148.281,150.523,153.302,160.278,165.263,168.751,172.239,174.481" y="598.9929999999999" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Clin. J. Oncol. Nurs. </text>
  <text x="177.258,181.741,186.224,190.708" y="598.9929999999999" svg_rhmargin="195.191" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="197.433" x="195.191,197.433" y="598.9929999999999" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="199.674,204.157" y="598.9929999999999" svg_rhmargin="208.64" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">21</text>
  <text x="208.641,210.88299999999998,213.124,217.607,222.091,226.574,231.057,235.54,237.78199999999998,240.561,243.547,249.904,253.285,258.18,261.982,265.784,271.773,276.068,279.054,282.03999999999996,284.282,287.267,292.683,298.09,303.048,311.53,315.825,321.304" y="598.9929999999999" svg_rhmargin="324.29" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 29–34. [CrossRef] [PubMed]</text>
  <text x="76.535,81.018,85.501,87.74300000000001,98.05,103.965,109.126,113.56,118.721,123.651,125.868,128.103,135.073,137.29,139.507,141.742,147.656,152.817,157.251,162.412,167.343,169.56,171.794,177.709,179.926,182.143,184.378,189.734,193.982,199.143,204.073,206.29000000000002,208.516,216.905,219.122,221.33900000000003,223.573,228.504,233.851,236.068,238.303,242.958,245.175,247.39200000000002,249.627,255.542,260.889,265.137,267.354,269.588,275.503,277.72,279.937,282.172,288.086,293.247,297.681,302.842,307.773,309.99,312.224,318.148,320.365,322.591,328.878,335.777,341.701,344.654,350.09,352.325,356.262,360.51,363.09,365.671,367.905,370.796,375.957,380.205,383.708,388.142,393.471,398.402,400.636,403.217,408.378,410.604,415.534,419.968,423.728,426.619,429.962,434.804,437.384,442.545,445.436,449.684,453.444,456.335,458.915,464.076,468.51,471.091,473.325,476.216,481.564,489.394,494.236,497.738,501.498,503.724,508.158,513.319" y="611.905" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">12. Zhang, Q.; Zhang, Z.; Peng, M.; Fu, S.; Xue, Z.; Zhang, R. CAR-T cell therapy in gastrointestinal tumors and</text>
  <text svg_rhmargin="267.713" x="98.05,103.268,107.563,112.952,117.435,120.358,122.968,126.949,129.19,133.171,137.655,141.035,145.016,147.625,152.844,157.739,165.657,170.14,172.38199999999998,175.161,180.146,183.527,188.422,196.339,198.581,203.54,207.835,213.053,217.034,222.25199999999998,224.494,227.417,232.312,234.555,239.513,243.808,249.286,253.088,255.697,261.176,265.471,267.713" y="624.816" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">hepatic carcinoma: From bench to bedside. </text>
  <text svg_rhmargin="335.918" x="270.49,277.466,282.451,286.1,290.082,292.574,299.55,306.526,311.511,316.497,320.478,322.97,326.951,331.435,335.918" y="624.816" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Oncoimmunology </text>
  <text x="338.158,342.641,347.124,351.608" y="624.816" svg_rhmargin="356.091" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text svg_rhmargin="358.333" x="356.091,358.333" y="624.816" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="360.574" y="624.816" svg_rhmargin="365.057" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">5</text>
  <text x="365.057,367.29900000000004,369.54,373.835,378.318,382.802,387.285,391.768,396.251,400.734,405.218,407.46000000000004,410.239,413.225,419.582,422.962,427.858,431.659,435.461,441.451,445.746,448.732" y="624.816" svg_rhmargin="451.718" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, e1251539. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="637.7280000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">13. </text>
  <text x="98.05,102.936,107.145,110.87,115.984,120.378,125.264,127.461,129.235,136.072,138.268,140.465,142.39,147.758,150.315,155.43,157.627,159.401,165.631,167.828,170.025,171.949,176.562,179.12,183.329,188.214,192.423,194.98,197.177,198.943,205.744,207.941,213.31,215.507,217.704,219.637,227.949,232.343,237.641,241.367,243.564,245.33,253.643,255.839,261.033,263.23,264.996,271.226,278.062,283.932,286.858,292.244,294.019,300.249,304.458,307.015,309.572,311.339,316.725,321.839,326.048,329.519,333.913,339.194,341.751,345.96,349.686,351.46,356.346,359.65,364.448,372.207,373.982,376.846,381.96,386.169,387.944,392.522,395.993,400.387,405.501,409.227,412.153,417.451,421.177,423.734,428.532,433.64599999999996,435.412,443.725,447.934,453.302,455.859,459.761,462.318,467.432,471.641,473.416,478.723,482.932,486.403,490.129,495.41,499.619,503.521,506.385,508.942,513.907,518.116" y="637.7280000000001" svg_rhmargin="520.313" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Fesnak, A.; Lin, C.; Siegel, D.L.; Maus, M.V. CAR-T Cell Therapies From the Transfusion Medicine Perspective.</text>
  <text svg_rhmargin="171.074" x="97.504,101.987,105.475,109.456,114.442,117.929,120.422,125.407,128.895,131.137,133.917,142.381,145.869,150.352,152.594,155.373,161.354,164.842,168.832,171.07399999999998" y="650.64" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Transfus. Med. Rev. </text>
  <text x="173.851,178.334,182.817,187.301" y="650.64" svg_rhmargin="191.784" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text svg_rhmargin="194.026" x="191.784,194.02599999999998" y="650.64" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="196.267,200.75" y="650.64" svg_rhmargin="205.233" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">30</text>
  <text x="205.234,207.476,209.717,214.2,218.684,223.167,227.65,232.133,236.616,241.1,243.34199999999998,246.121,249.107,255.464,258.844,263.74,267.542,271.343,277.333,281.628,284.614,287.59999999999997,289.841,292.827,298.242,303.649,308.608,317.09,321.385,326.863" y="650.64" svg_rhmargin="329.849" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 139–145. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="663.5509999999999" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">14. </text>
  <text x="98.05,105.239,107.781,113.89,118.884,124.399,128.011,133.096,137.477,139.764,145.599,152.677,154.964,163.616,165.902,168.189,175.825,183.425,187.998,191.876,195.489,200.061,202.723,205.384,209.957,215.28,217.567,223.411,232.062,234.349,238.711,240.998,243.285,250.921,258.0,262.38,266.258,270.831,273.493,275.78,281.623,288.738,291.025,293.31199999999995,300.948,309.6,313.981,316.642,321.023,326.346,331.669,336.662,340.275,344.152,347.134,349.421,355.255,358.301,360.587,363.633,365.919,368.20599999999996,375.842,384.494,389.067,394.39,398.268,403.801,408.182,410.843,416.431,418.71799999999996,424.562,431.201,433.488,435.775,443.411,452.063,457.056,460.669,464.282,466.943,470.821,474.699,479.079,482.061,485.042,489.423,491.71,497.545,500.59,502.876,505.922,508.208,515.287,517.574" y="663.5509999999999" svg_rhmargin="519.86" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">O’Rourke, D.M.; Nasrallah, M.P.; Desai, A.; Melenhorst, J.J.; Mansﬁeld, K.; Morrissette, J.J.D.;</text>
  <text x="98.05,106.702,111.275,114.887,117.869,120.53,125.853,130.234,134.807,137.852,143.44,148.013,153.098,157.479,159.76600000000002,164.238,172.889,175.176,177.463,183.041,188.629,192.077,196.458,204.534,206.821,211.292,216.094,218.38,220.667,226.246,234.898,239.47,242.132,247.125,252.448,256.829,260.917,263.20399999999995,267.676,273.264,275.55,277.837,283.416,288.217,293.54,297.921,303.244,305.531,310.002,317.118,319.404,321.691,327.269,331.65,334.632,339.104,343.677,346.338,348.625,358.081,365.197,369.66,373.538,376.199,381.522,386.607,389.268,393.649,398.121,403.709,408.703,412.581,416.962,421.434,426.427,429.473,433.936,439.433,443.813,447.426,450.087,455.584,460.907,465.288,468.9,473.473,476.134,478.796,483.881,488.353,491.014,496.337,499.383,504.898,508.775,513.156" y="676.463" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Martinez-Lage, M.; Brem, S.; Maloney, E.; Shen, A.; et al. A single dose of peripherally infused</text>
  <text x="98.05,103.638,110.616,115.701,121.811,126.978,130.06,133.142,136.224,139.27,144.858,147.519,150.967,155.348,159.409,162.39,166.771,172.35899999999998,175.469,181.953,189.068,195.17800000000003,198.287,203.893,207.003,211.064,215.445,218.106,220.767,224.64499999999998,227.764,235.84,240.22,245.808,248.461,253.033,256.015,260.396,264.274,267.392,271.965,277.288,280.269,282.931,288.016,292.397,297.71999999999997,300.829,303.49,308.484,312.362,316.24,319.349,323.922,329.245,334.833,337.942,340.604,345.927,351.515,357.03,361.09,365.471,369.349,372.458,377.031,382.619,387.192,392.689,395.67,398.332,403.499,407.88,410.989,414.437,418.818,422.696,425.357,429.235,432.217,436.789,442.112,446.173,450.554,453.663,456.325,461.64799999999997,464.766,470.263,474.836,477.817,480.469,484.85,490.173,493.155,497.03299999999996,500.151,507.779,510.44,513.421" y="689.374" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with</text>
  <text svg_rhmargin="190.126" x="98.05,101.43,105.725,109.706,115.113,118.655,122.035,126.33,131.548,134.471,136.713,141.698,144.308,146.917,151.813,156.771,159.38,163.863,167.665,170.588,175.484,183.401,187.884,190.12599999999998" y="702.2860000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">recurrent glioblastoma. </text>
  <text svg_rhmargin="255.67" x="192.905,197.89,201.54,204.032,206.274,209.053,213.537,217.025,221.006,225.991,229.479,231.972,234.214,236.993,245.457,248.945,253.428,255.67" y="702.2860000000001" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Sci. Transl. Med. </text>
  <text x="258.448,262.931,267.414,271.898" y="702.2860000000001" svg_rhmargin="276.381" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="278.623" x="276.381,278.623" y="702.2860000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="280.864" y="702.2860000000001" svg_rhmargin="285.347" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">9</text>
  <text x="285.347,287.589,289.83,294.125,298.608,303.092,307.575,312.058,316.541,321.024,325.508,327.75,330.529,333.515,339.872,343.252,348.148,351.95,355.751,361.741,366.036,369.022,372.008,374.249,377.235,382.65,388.057,393.016,401.498,405.793,411.271" y="702.2860000000001" svg_rhmargin="414.257" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, eaaa0984. [CrossRef] [PubMed]</text>
 </g>
</svg>
